Better Therapeutics

Business model

FDA-cleared prescription digital therapeutic app for treating type 2 diabetes and cardiometabolic disease through behavioral change.

In brief

Developed an FDA-authorized software treatment (not a drug) that used cognitive behavioral therapy techniques delivered via app to help manage type 2 diabetes, going public via SPAC in 2023. The same reimbursement and adoption headwinds facing the broader prescription-digital-the…

See the What Happened tab for the full account.